Regulatory factors in the development of fatty infiltration of the liver during gram-negative sepsis.
To further understand the development of fatty liver during gram-negative sepsis, we measured fatty acid uptake in addition to esterification and secretion of lipids by freshly isolated hepatocytes from fasted and fed control and Escherichia coli-treated rats. Rats were made septic by intravenous (IV) injection of 8 x 10(7) live E coli colonies per 100 g body weight. For the fasted groups, food was removed after E coli injection. Fed rats received a nutritionally adequate diet intragastrically for 5 days before and 24 hours after inducing sepsis. Twenty-four hours after E coli injection, the esterification of newly synthesized fatty acids, as measured by 3H2O incorporation, and the esterification of exogenous fatty acids, measured from 14C-palmitate incorporation, into triglyceride (TG), total cholesterol, and total phospholipid phosphorus were significantly greater in hepatocytes from fasted septic rats compared with their control rats. In fed septic rats, esterification of 14C-palmitate into TG was fourfold greater than in the fed control rats. The increased rates of esterification in hepatocytes from fasted and fed septic rats were not accompanied by an increase in the labeled TG in the medium. This inability to secrete the additional TG that the hepatocytes produce resulted in a higher concentration of cellular TG in fasted and fed septic rats than in their controls. The enzymes glycerol-3-phosphate acyltransferase (GPAT) and phosphatidate phosphohydrolase (PPH) do not appear to be factors contributing to the increased TG synthesis, since the increase in enzyme activity was not accompanied by a similar increase in TG synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)
Lanza-Jacoby
S
S
Department of Surgery, Jefferson Medical College, Philadelphia, PA 19107.
Rosato
E L
EL
D000818:Animals; D002784:Cholesterol / Q000096:biosynthesis / Q000378:metabolism; D003470:Culture Media / Q000737:chemistry; D004927:Escherichia coli Infections; D005230:Fatty Acids, Nonesterified / Q000493:pharmacokinetics; D005234:Fatty Liver / Q000378:metabolism / Q000382:microbiology*; D005992:Glycerol-3-Phosphate O-Acyltransferase / Q000378:metabolism; D005994:Glycerophosphates / Q000378:metabolism; D016905:Gram-Negative Bacterial Infections; D006801:Humans; D008099:Liver / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D008297:Male; D010711:Phosphatidate Phosphatase / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D014280:Triglycerides / Q000096:biosynthesis / Q000378:metabolism
D003470:Culture Media; D005230:Fatty Acids, Nonesterified; D005994:Glycerophosphates; D014280:Triglycerides; D002784:Cholesterol; D005992:Glycerol-3-Phosphate O-Acyltransferase; D010711:Phosphatidate Phosphatase